Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash Flows from Operating Activities:    
Net Loss $ (102,521) $ (73,818)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation expense 1,379 819
Amortization expense of intangible asset 2,100 1,235
Amortization of debt discount 624 1,316
Amortization of product revenue license fee 433 401
Amortization of forgivable loans to registered representatives 474 520
Amortization of deferred clearing credit (157) (157)
Stock-based compensation expense 13,658 12,048
Recovery of doubtful accounts 18 (274)
Common shares issuable for 2017 Subordinated Note financing interest expense 495 353
Common shares issued for 2017 Subordinated Note financing interest expense 978 189
Common shares issued for Opus interest expense 574 0
Change in fair value of investments 1,390 241
Change in fair value of derivative liabilities 7,931 (5,155)
Change in fair value of subsidiary convertible note (26) 359
Loss on write off of investment 0 250
Research and development-licenses acquired, expense 3,804 3,394
Non-cash research and development expense 0 50
Change in fair value of subsidiaries' assets and liabilities 18 1,341
Increase (decrease) in cash and cash equivalents resulting from changes in operating assets and liabilities:    
Accounts receivable 2,327 (3,752)
Receivables from broker-dealers and clearing organizations (4,489) (4,925)
Forgivable loans receivable (468) (77)
Securities owned, at fair value (4,690) 762
Inventory (503) (115)
Other receivables - related party 204 1,152
Prepaid expenses and other current assets (562) (1,426)
Other assets 200 0
Accounts payable and accrued expenses (980) 4,195
Accounts payable and accrued expense - related party (19) 84
Securities sold, but not yet purchased, at fair value (127) (298)
Deferred Revenue 155 680
Interest payable (274) 22
Interest payable - related party (3) 430
Other long-term liabilities 222 (288)
Net cash used in operating activities (77,835) (60,444)
Cash Flows from Investing Activities:    
Purchase of research and development licenses (1,075) (965)
Purchase of property and equipment (6,828) (999)
Purchase of short-term investment (certificates of deposit) (47,538) (44,088)
Redemption of short-term investment (certificates of deposit) 61,002 0
Security deposits collected (344) 0
Security deposits refund 0 42
Acquisition of business - National (187) (19)
Acquisition of intangible assets - National (45) 0
Collection on notes receivable 69 28
Net cash provided by (used in) investing activities 5,054 (46,001)
Cash Flows from Financing Activities:    
Inter-company costs related to the issuance of Series A preferred stock 1,297 0
Payment of Preferred A dividends (1,758) 0
Proceeds from at-the-market offering 6,959 0
Payment of costs related to at-the-market offering (240) 0
Proceeds from subsidiaries' offering 23,011 104,034
Payment of costs related to subsidiaries' offering (343) (9,389)
Proceeds from subsidiaries' at-the-market offering 7,980 0
Payment of costs related to subsidiaries' at-the-market offering (234) 0
Proceeds from exercise of subsidiary's warrants 186 0
Proceeds from 2017 Subordinated Note Financing 0 28,355
Payment of debt issuance costs associated with 2017 Subordinated Note Financing (404) (1,081)
Payment of debt issuance costs associated with NSC Note 0 (3,608)
Proceeds from exercise of stock options 0 27
Proceeds from issuance of common stock under ESPP 128 42
Repurchase of NHLD common stock for tax withholding (82) 0
Proceeds from 2018 Venture notes 21,707 0
Payment of debt issuance costs associated with 2018 Venture notes (132) 0
Proceeds from subsidiaries' Convertible Note 0 9,914
Payment of debt issuance costs associated with subsidiaries' Convertible Note 0 (1,071)
Payment of subsidiaries' Convertible Note (4,076) 0
Proceeds from Opus Credit Facility 0 2,500
Net cash provided by financing activities 53,999 129,723
Net (decrease) increase in cash and cash equivalents, cash deposits with clearing organizations and restricted cash (18,782) 23,278
Cash and cash equivalents, cash deposits with clearing organizations and restricted cash at beginning of period 132,343 105,184
Cash and cash equivalents, cash deposits with clearing organizations and restricted cash at end of period 113,561 128,462
Supplemental disclosure of cash flow information:    
Cash paid for interest 13 11
Supplemental disclosure of non-cash financing and investing activities:    
Issuance of restricted stock 2 2
Issuance of warrants by subsidiary in conjunction with NSC debt 0 750
Issuance of warrants in connection with 2017 Subordinated Note Financing 0 1,784
Debt discount related to Opus Credit Facility 0 201
Unpaid debt offering cost 0 42
Common shares issuable for license acquired 0 1,682
Conversion of subsidiaries notes payable 0 314
Common shares issued for 2017 Subordinated Note Financing interest expense 500 0
Unpaid subsidiary's ATM offering cost 20 0
Fixed assets (acquired but not paid) 537 665
Business acquisition 187 19
Reclassification of warrant liability from debt to equity 13,615 0
Parent Company [Member]    
Supplemental disclosure of non-cash financing and investing activities:    
Unpaid intangible assets – Fortress Companies 1,200 0
National [Member]    
Supplemental disclosure of cash flow information:    
Cash paid for interest 3,767 345
Cash paid for income taxes 1,569 1,004
Fortress [Member]    
Supplemental disclosure of non-cash financing and investing activities:    
Fixed assets (acquired but not paid) 125 0
Related Party [Member]    
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 281 $ 0